Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-28

Clinical Trial Update: Cyclophosphamide Versus Mycophenolate Mofetil in Lupus Nephritis [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing cyclophosphamide to mycophenolate mofetil in lupus nephritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Chitwan Medical College | Conditions: To Compare the Effects of Mycophenolate Mofetil With Cyclophosphamide in Neplaese Lupus Nephritis Patients | Phase 2 | Status: COMPLETED